Find Research Outputs

Search in all content

Filters for Research Output

Search concepts
Selected Filters

Publication Year

  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011

Author

  • Ruben Mesa
2020

Associations Between Global Mental Health and Response to an App-Based Meditation Intervention in Myeloproliferative Neoplasm Patients

Puzia, M. E., Huberty, J., Eckert, R., Larkey, L. & Mesa, R., 2020, In : Integrative Cancer Therapies. 19

Research output: Contribution to journalArticle

Open Access

Carotenoid Intake and Circulating Carotenoids Are Inversely Associated with the Risk of Bladder Cancer: A Dose-Response Meta-analysis

Wu, S., Liu, Y., Michalek, J. E., Mesa, R. A., Parma, D. L., Rodriguez, R., Mansour, A. M., Svatek, R., Tucker, T. C. & Ramirez, A. G., May 1 2020, In : Advances in nutrition (Bethesda, Md.). 11, 3, p. 630-643 14 p.

Research output: Contribution to journalArticle

1 Scopus citations

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

COVID-19 and Cancer Consortium, Jun 20 2020, In : The Lancet. 395, 10241, p. 1907-1918 12 p.

Research output: Contribution to journalArticle

Open Access
15 Scopus citations

Early post-transplantation factors predict survival outcomes in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis

Jain, T., Kunze, K. L., Mountjoy, L., Partain, D. K., Kosiorek, H., Khera, N., Hogan, W. J., Roy, V., Slack, J. L., Noel, P., Fauble, V. D. S., Leis, J. F., Sproat, L., Tefferi, A., Patnaik, M. M., Mesa, R. A. & Palmer, J., Mar 1 2020, In : Blood Cancer Journal. 10, 3, 36.

Research output: Contribution to journalArticle

Open Access

Fedratinib in myelofibrosis

Mullally, A., Hood, J., Harrison, C. & Mesa, R., Apr 28 2020, In : Blood Advances. 4, 8, p. 1792-1800 9 p.

Research output: Contribution to journalArticle

Open Access
1 Scopus citations

Fedratinib in patients with myelofibrosis previously treated with ruxolitinib: An updated analysis of the JAKARTA2 study using stringent criteria for ruxolitinib failure

Harrison, C. N., Schaap, N., Vannucchi, A. M., Kiladjian, J. J., Jourdan, E., Silver, R. T., Schouten, H. C., Passamonti, F., Zweegman, S., Talpaz, M., Verstovsek, S., Rose, S., Shen, J., Berry, T., Brownstein, C. & Mesa, R. A., Jun 1 2020, In : American Journal of Hematology. 95, 6, p. 594-603 10 p.

Research output: Contribution to journalArticle

Open Access
3 Scopus citations

Lifestyle factors and risk of myeloproliferative neoplasms in the NIH-AARP diet and health study

Podoltsev, N. A., Wang, X., Wang, R., Hofmann, J. N., Liao, L. M., Zeidan, A. M., Mesa, R. & Ma, X., Jan 1 2020, (Accepted/In press) In : International Journal of Cancer. 147, 4, p. 948-957 10 p.

Research output: Contribution to journalArticle

2 Scopus citations

Long-term efficacy and safety of ruxolitinib versus best available therapy in polycythaemia vera (RESPONSE): 5-year follow up of a phase 3 study

Kiladjian, J. J., Zachee, P., Hino, M., Pane, F., Masszi, T., Harrison, C. N., Mesa, R., Miller, C. B., Passamonti, F., Durrant, S., Griesshammer, M., Kirito, K., Besses, C., Moiraghi, B., Rumi, E., Rosti, V., Blau, I. W., Francillard, N., Dong, T., Wroclawska, M. & 2 others, Vannucchi, A. M. & Verstovsek, S., Mar 2020, In : The Lancet Haematology. 7, 3, p. e226-e237

Research output: Contribution to journalArticle

8 Scopus citations

Management of challenging myelofibrosis after JAK inhibitor failure and/or progression

Scherber, R. M. & Mesa, R. A., 2020, (Accepted/In press) In : Blood Reviews. 100716.

Research output: Contribution to journalReview article

Management of myelofibrosis after ruxolitinib failure

Harrison, C. N., Schaap, N. & Mesa, R. A., Jun 1 2020, In : Annals of Hematology. 99, 6, p. 1177-1191 15 p.

Research output: Contribution to journalReview article

Open Access
2 Scopus citations

Real-World Outcomes of Ruxolitinib Treatment for Polycythemia Vera

Coltoff, A., Mesa, R., Gotlib, J., Shulman, J., Rampal, R. K., Siwoski, O., Yacoub, A., Moliterno, A., Yang, A., Braunstein, E., Gerds, A. T., Hobbs, G. S., Winton, E. F., Goel, S., Wadleigh, M., Tremblay, D., Moshier, E. & Mascarenhas, J., 2020, (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

Real-world risk assessment and treatment initiation among patients with myelofibrosis at community oncology practices in the United States

Verstovsek, S., Yu, J., Kish, J. K., Paranagama, D., Kaufman, J., Myerscough, C., Grunwald, M. R., Colucci, P. & Mesa, R., Jan 1 2020, (Accepted/In press) In : Annals of Hematology.

Research output: Contribution to journalArticle

Open Access

Reply to comments on: Lifestyles and myeloproliferative neoplasms with special reference to coffee consumption

Podoltsev, N. A., Wang, X., Wang, R., Hofmann, J. N., Liao, L. M., Zeidan, A. M., Mesa, R. & Ma, X., Jun 15 2020, In : International Journal of Cancer. 146, 12, 1 p.

Research output: Contribution to journalLetter

Safety and efficacy of the maximum tolerated dose of givinostat in polycythemia vera: a two-part Phase Ib/II study

Rambaldi, A., Iurlo, A., Vannucchi, A. M., Noble, R., von Bubnoff, N., Guarini, A., Martino, B., Pezzutto, A., Carli, G., De Muro, M., Luciani, S., McMullin, M. F., Cambier, N., Marolleau, J. P., Mesa, R. A., Tibes, R., Pancrazzi, A., Gesullo, F., Bettica, P., Manzoni, S. & 1 others, Di Tollo, S., Aug 1 2020, In : Leukemia. 34, 8, p. 2234-2237 4 p.

Research output: Contribution to journalArticle

Open Access
1 Scopus citations

Severe thrombocytopenia in myelofibrosis is more prevalent than previously reported

Masarova, L., Mesa, R. A., Hernández-Boluda, J. C. & Taylor, J. A., Apr 2020, In : Leukemia Research. 91, 106338.

Research output: Contribution to journalLetter

Single-cell proteomic profiling identifies combined AXL and JAK1 inhibition as a novel therapeutic strategy for lung cancer

Taverna, J. A., Hung, C. N., DeArmond, D. T., Chen, M., Lin, C. L., Osmulski, P. A., Gaczynska, M. E., Wang, C. M., Lucio, N. D., Chou, C. W., Chen, C. L., Nazarullah, A., Lampkin, S. R., Qiu, L., Bearss, D. J., Warner, S., Whatcott, C. J., Mouritsen, L., Wade, M., Weitman, S. & 4 others, Mesa, R. A., Kirma, N. B., Chao, W. T. & Huang, T. H. M., Apr 1 2020, In : Cancer Research. 80, 7, p. 1551-1563 13 p.

Research output: Contribution to journalArticle

1 Scopus citations

Survival following allogeneic transplant in patients with myelofibrosis

Gowin, K., Ballen, K., Ahn, K. W., Hu, Z. H., Ali, H., Arcasoy, M. O., Devlin, R., Coakley, M., Gerds, A. T., Green, M., Gupta, V., Hobbs, G., Jain, T., Kandarpa, M., Komrokji, R., Kuykendall, A. T., Luber, K., Masarova, L., Michaelis, L. C., Patches, S. & 48 others, Pariser, A. C., Rampal, R., Stein, B., Talpaz, M., Verstovsek, S., Wadleigh, M., Agrawal, V., Aljurf, M., Diaz, M. A., Avalos, B. R., Bacher, U., Bashey, A., Beitinjaneh, A. M., Cerny, J., Chhabra, S., Copelan, E., Cutler, C. S., DeFilipp, Z., Gadalla, S. M., Ganguly, S., Grunwald, M. R., Hashmi, S. K., Kharfan-Dabaja, M. A., Kindwall-Keller, T., Kröger, N., Lazarus, H. M., Liesveld, J. L., Litzow, M. R., Marks, D. I., Nathan, S., Nishihori, T., Olsson, R. F., Pawarode, A., Rowe, J. M., Savani, B. N., Savoie, M. L., Seo, S., Solh, M., Tamari, R., Verdonck, L. F., Yared, J. A., Alyea, E., Popat, U., Sobecks, R., Scott, B. L., Nakamura, R., Mesa, R. & Saber, W., May 12 2020, In : Blood Advances. 4, 9, p. 1966-1973 8 p.

Research output: Contribution to journalArticle

Open Access

Treatment Patterns and Blood Counts in Patients With Polycythemia Vera Treated With Hydroxyurea in the United States: An Analysis From the REVEAL Study

Grunwald, M. R., Kuter, D. J., Altomare, I., Burke, J. M., Gerds, A. T., Walshauser, M. A., Savona, M. R., Stein, B., Oh, S. T., Colucci, P., Parasuraman, S., Paranagama, D. & Mesa, R., Apr 2020, In : Clinical Lymphoma, Myeloma and Leukemia. 20, 4, p. 219-225 7 p.

Research output: Contribution to journalArticle

Open Access
2019

A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis

Mascarenhas, J., Kosiorek, H., Prchal, J., Yacoub, A., Berenzon, D., Baer, M. R., Ritchie, E., Silver, R. T., Kessler, C., Winton, E., Finazzi, M. C., Rambaldi, A., Vannucchi, A. M., Leibowitz, D., Rondelli, D., Arcasoy, M. O., Catchatourian, R., Vadakara, J., Rosti, V., Hexner, E. & 12 others, Kremyanskaya, M., Sandy, L., Tripodi, J., Najfeld, V., Farnoud, N., Salama, M. E., Weinberg, R. S., Rampal, R., Goldberg, J. D., Mesa, R., Dueck, A. C. & Hoffman, R., Dec 1 2019, In : Leukemia. 33, 12, p. 2974-2978 5 p.

Research output: Contribution to journalLetter

3 Scopus citations

Assessment of Quality of Life following Allogeneic Stem Cell Transplant for Myelofibrosis

Palmer, J., Kosiorek, H. E., Wolschke, C., Fauble, V. D. S., Butterfield, R., Geyer, H., Scherber, R. M., Dueck, A. C., Gathany, A., Mesa, R. A. & Kroger, N., Nov 2019, In : Biology of Blood and Marrow Transplantation. 25, 11, p. 2267-2273 7 p.

Research output: Contribution to journalArticle

2 Scopus citations

Corrigendum to “Phase 1/2 trial of glasdegib in patients with primary or secondary myelofibrosis previously treated with ruxolitinib” [Leukemia Res. 79 (2019) 38–44] (Leukemia Research (2019) 79 (38–44), (S0145212619300384), (10.1016/j.leukres.2019.02.012))

Gerds, A. T., Tauchi, T., Ritchie, E., Deininger, M., Jamieson, C., Mesa, R., Heaney, M., Komatsu, N., Minami, H., Su, Y., Shaik, N., Zhang, X., DiRienzo, C., Zeremski, M., Chan, G. & Talpaz, M., Jun 2019, In : Leukemia Research. 81, 1 p.

Research output: Contribution to journalComment/debate

Open Access

Development of a symptom assessment in patients with myelofibrosis: Qualitative study findings

Mesa, R. A., Su, Y., Woolfson, A., Prchal, J. T., Turnbull, K., Jabbour, E., Scherber, R., Shields, A. L., Krohe, M., Ojo, F., Pompilus, F., Cappelleri, J. C. & Harrison, C., Apr 11 2019, In : Health and Quality of Life Outcomes. 17, 1, 61.

Research output: Contribution to journalArticle

Open Access

Experiences of using a consumer-based mobile meditation app to improve fatigue in myeloproliferative patients: Qualitative study

Huberty, J., Eckert, R., Larkey, L., Joeman, L. & Mesa, R., Jul 1 2019, In : Journal of Medical Internet Research. 21, 7, e14292.

Research output: Contribution to journalArticle

Open Access

Facing erythrocytosis: Results of an international physician survey

Rumi, E., McMullin, M. F., Harrison, C., Ellis, M. H., Barzilai, M., Sarid, N., Mesa, R., Paoli, C., Angona, A., Sant'Antonio, E., Ferretti, V. V., Cavalloni, C., Casetti, I. C., Trotti, C. & Barbui, T., Jan 1 2019, In : American Journal of Hematology. 94, 9, p. E225-E227

Research output: Contribution to journalLetter

Open Access
2 Scopus citations

Impact of High-Molecular-Risk Mutations on Transplantation Outcomes in Patients with Myelofibrosis

Tamari, R., Rapaport, F., Zhang, N., McNamara, C., Kuykendall, A., Sallman, D. A., Komrokji, R., Arruda, A., Najfeld, V., Sandy, L., Medina, J., Litvin, R., Famulare, C. A., Patel, M. A., Maloy, M., Castro-Malaspina, H., Giralt, S. A., Weinberg, R. S., Mascarenhas, J. O., Mesa, R. & 6 others, Rondelli, D., Dueck, A. C., Levine, R. L., Gupta, V., Hoffman, R. & Rampal, R. K., Jun 2019, In : Biology of Blood and Marrow Transplantation. 25, 6, p. 1142-1151 10 p.

Research output: Contribution to journalArticle

10 Scopus citations

Online yoga in myeloproliferative neoplasm patients: Results of a randomized pilot trial to inform future research

Huberty, J., Eckert, R., Dueck, A., Kosiorek, H., Larkey, L., Gowin, K. & Mesa, R., Jun 7 2019, In : BMC Complementary and Alternative Medicine. 19, 1, 121.

Research output: Contribution to journalArticle

Open Access

Oral idasanutlin in patients with polycythemia vera

Mascarenhas, J., Lu, M., Kosiorek, H., Virtgaym, E., Xia, L., Sandy, L., Mesa, R., Petersen, B., Farnoud, N., Najfeld, V., Rampal, R., Dueck, A. & Hoffman, R., Aug 8 2019, In : Blood. 134, 6, p. 525-533 9 p.

Research output: Contribution to journalArticle

Open Access
10 Scopus citations

Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea

Yacoub, A., Mascarenhas, J., Kosiorek, H., Prchal, J. T., Berenzon, D., Baer, M. R., Ritchie, E., Silver, R. T., Kessler, C., Winton, E., Finazzi, M. C., Rambaldi, A., Vannucchi, A. M., Leibowitz, D., Rondelli, D., Arcasoy, M. O., Catchatourian, R., Vadakara, J., Rosti, V., Hexner, E. & 14 others, Kremyanskaya, M., Sandy, L., Tripodi, J., Najfeld, V., Farnoud, N., Papaemmanuil, E., Salama, M., Singer-Weinberg, R., Rampal, R., Goldberg, J. D., Barbui, T., Mesa, R., Dueck, A. C. & Hoffman, R., Oct 31 2019, In : Blood. 134, 18, p. 1498-1509 12 p.

Research output: Contribution to journalArticle

Open Access
11 Scopus citations

Phase 1/2 trial of glasdegib in patients with primary or secondary myelofibrosis previously treated with ruxolitinib

Gerds, A. T., Tauchi, T., Ritchie, E., Deininger, M., Jamieson, C., Mesa, R., Heaney, M., Komatsu, N., Minami, H., Su, Y., Shaik, N., Zhang, X., DiRienzo, C., Zeremski, M., Chan, G. & Talpaz, M., Apr 2019, In : Leukemia Research. 79, p. 38-44 7 p.

Research output: Contribution to journalArticle

10 Scopus citations

Predictive models for splenic response to JAK-inhibitor therapy in patients with myelofibrosis

Menghrajani, K., Boonstra, P. S., Mercer, J. A., Perkins, C., Gowin, K. L., Weber, A. A., Mesa, R., Gotlib, J. R., Wang, L., Singer, J. W. & Talpaz, M., Mar 21 2019, In : Leukemia and Lymphoma. 60, 4, p. 1036-1042 7 p.

Research output: Contribution to journalArticle

1 Scopus citations

Proactive steps to optimize the management of polycythemia vera and myelofibrosis

Mesa, R. A., Sep 2019, In : Clinical Advances in Hematology and Oncology. 17, 9, p. 475-477 3 p.

Research output: Contribution to journalComment/debate

Quality of life and symptom burden among myeloproliferative neoplasm patients: do symptoms impact quality of life?

Langlais, B. T., Geyer, H., Scherber, R., Mesa, R. A. & Dueck, A. C., Jan 28 2019, In : Leukemia and Lymphoma. 60, 2, p. 402-408 7 p.

Research output: Contribution to journalArticle

1 Scopus citations

Ruxolitinib Therapy Followed by Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation for Myelofibrosis: Myeloproliferative Disorders Research Consortium 114 Study

Gupta, V., Kosiorek, H. E., Mead, A., Klisovic, R. B., Galvin, J. P., Berenzon, D., Yacoub, A., Viswabandya, A., Mesa, R. A., Goldberg, J., Price, L., Salama, M. E., Weinberg, R. S., Rampal, R., Farnoud, N., Dueck, A. C., Mascarenhas, J. O. & Hoffman, R., Feb 2019, In : Biology of Blood and Marrow Transplantation. 25, 2, p. 256-264 9 p.

Research output: Contribution to journalArticle

9 Scopus citations

Smartphone-based meditation for myeloproliferative neoplasm patients: Feasibility study to inform future trials

Huberty, J., Eckert, R., Larkey, L., Kurka, J., De Jesús, S. A. R., Yoo, W. & Mesa, R., Apr 2019, In : Journal of Medical Internet Research. 21, 4, e12662.

Research output: Contribution to journalArticle

Open Access
3 Scopus citations

Symptom Burden and Blood Counts in Patients With Polycythemia Vera in the United States: An Analysis From the REVEAL Study

Grunwald, M. R., Burke, J. M., Kuter, D. J., Gerds, A. T., Stein, B., Walshauser, M. A., Parasuraman, S., Colucci, P., Paranagama, D., Savona, M. R. & Mesa, R., Jan 1 2019, In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

Open Access
1 Scopus citations
2018

99mTc-sulfur colloid bone marrow scintigraphy in diagnosis of diffuse pulmonary extramedullary hematopoiesis secondary to myelofibrosis

Yang, M., Covington, M. F., Nguyen, B. D., Johnson, G. B., Mesa, R. & Roarke, M. C., Dec 1 2018, In : Journal of Nuclear Medicine Technology. 46, 4, p. 368-372 5 p.

Research output: Contribution to journalArticle

2 Scopus citations

AlternativeOutpatientChemotherapy scheduling method to improve patient service quality and nurse satisfaction

Huang, Y. L., Bryce, A. H., Culbertson, T., Connor, S. L., Looker, S. A., Altman, K. M., Collins, J. G., Stellner, W., McWilliams, R. R., Moreno-Aspitia, A., Ailawadhi, S. & Mesa, R. A., Feb 1 2018, In : Journal of Oncology Practice. 14, 2, p. e82-e91

Research output: Contribution to journalArticle

1 Scopus citations

Clinical and Disease Characteristics From REVEAL at Time of Enrollment (Baseline): Prospective Observational Study of Patients With Polycythemia Vera in the United States

Grunwald, M. R., Stein, B. L., Boccia, R. V., Oh, S. T., Paranagama, D., Parasuraman, S., Colucci, P. & Mesa, R., Dec 2018, In : Clinical Lymphoma, Myeloma and Leukemia. 18, 12, p. 788-795.e2

Research output: Contribution to journalArticle

4 Scopus citations

Comparison of reduced intensity conditioning regimens used in patients undergoing hematopoietic stem cell transplantation for myelofibrosis

Jain, T., Kunze, K. L., Temkit, M., Partain, D. K., Patnaik, M. S., Slack, J. L., Khera, N., Hogan, W. J., Roy, V., Noel, P., Leis, J. F., Sproat, L. Z., Fauble, V., Mesa, R. & Palmer, J., May 24 2018, (Accepted/In press) In : Bone Marrow Transplantation. p. 1-8 8 p.

Research output: Contribution to journalArticle

12 Scopus citations

Emerging therapies for the treatment of essential thrombocythemia

Diaz, A. E., Scherber, R. M. & Mesa, R. A., Oct 3 2018, In : Expert Opinion on Orphan Drugs. 6, 10, p. 567-575 9 p.

Research output: Contribution to journalReview article

Impact of Myeloproliferative neoplasms on patients' employment status and work productivity in the United States: Results from the living with MPNs survey

Yu, J., Parasuraman, S., Paranagama, D., Bai, A., Naim, A., Dubinski, D. & Mesa, R., Apr 13 2018, In : BMC Cancer. 18, 1, 420.

Research output: Contribution to journalArticle

3 Scopus citations

Item nonresponse on the Myeloproliferative Neoplasms Symptom Assessment Form (MPN-SAF): a comparison of missing data strategies

Mazza, G. L., Kunze, K. L., Langlais, B. T., Kosiorek, H. E., DeWees, T. A., Geyer, H. L., Scherber, R. M., Mesa, R. A. & Dueck, A. C., Jan 1 2018, (Accepted/In press) In : Leukemia and Lymphoma.

Research output: Contribution to journalArticle

Living with Cancer: an Educational Intervention in Cancer Patients Can Improve Patient-Reported Knowledge Deficit

Padrnos, L., Bennett, R., Kosiorek, H., Dueck, A. C., Northfelt, D., Mikhael, J., Tibes, R., Khera, N. & Mesa, R., Jun 1 2018, In : Journal of Cancer Education. 33, 3, p. 653-659 7 p.

Research output: Contribution to journalArticle

1 Scopus citations
2 Scopus citations

Outcomes of patients with myelofibrosis treated with compassionate use pacritinib: a sponsor-independent international study

Mascarenhas, J., Virtgaym, E., Stal, M., Blacklock, H., Gerds, A. T., Mesa, R., Ganly, P., Snyder, D., Tabbara, I., Tremblay, D. & Moshier, E., Aug 1 2018, In : Annals of Hematology. 97, 8, p. 1369-1374 6 p.

Research output: Contribution to journalArticle

4 Scopus citations

Pacritinib and its use in the treatment of patients with myelofibrosis who have thrombocytopenia

Diaz, A. E. & Mesa, R. A., Apr 1 2018, In : Future Oncology. 14, 9, p. 797-807 11 p.

Research output: Contribution to journalArticle

3 Scopus citations